These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25342235)

  • 1. Pharmacological treatment and therapeutic perspectives of metabolic syndrome.
    Lim S; Eckel RH
    Rev Endocr Metab Disord; 2014 Dec; 15(4):329-41. PubMed ID: 25342235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmet needs in controlling metabolic disease.
    Haffner SM
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management issues in the metabolic syndrome.
    Deedwania PC; Gupta R
    J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic options for metabolic syndrome in obese patients].
    Carella AM; Conte M
    Clin Ter; 2007; 158(5):457-64. PubMed ID: 18062354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of the metabolic syndrome in obesity.
    Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Obes Rev; 2005 Nov; 6(4):283-96. PubMed ID: 16246214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and strategies in managing cardiometabolic risk.
    Repas TB
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular disease and metabolic syndrome].
    Maranghi M; Coletta P; Durante C; Pergolini D; Filetti S
    Recenti Prog Med; 2006 Dec; 97(12):719-26. PubMed ID: 17252730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome: definition and therapeutic implications.
    Prasad H; Ryan DA; Celzo MF; Stapleton D
    Postgrad Med; 2012 Jan; 124(1):21-30. PubMed ID: 22314111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating the metabolic syndrome.
    Bianchi C; Penno G; Romero F; Del Prato S; Miccoli R
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):491-506. PubMed ID: 17489673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome: nature, therapeutic solutions and options.
    Onat A
    Expert Opin Pharmacother; 2011 Aug; 12(12):1887-1900. PubMed ID: 21756201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological management of metabolic syndrome.
    Rask Larsen J; Dima L; Correll CU; Manu P
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):397-410. PubMed ID: 29345505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is type-2 diabetes mellitus preventable?].
    Jermendy G
    Orv Hetil; 2003 Sep; 144(39):1909-17. PubMed ID: 14598569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.
    Rosenson RS
    Curr Probl Cardiol; 2005 May; 30(5):241-79. PubMed ID: 15829899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should the insulin resistance syndrome be treated in the elderly?
    Grant RW; Meigs JB
    Drugs Aging; 2004; 21(3):141-51. PubMed ID: 14979733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options for modifying cardiometabolic risk factors.
    Aronne LJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S26-34. PubMed ID: 17320519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.